Century Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020
Market Capitalization	187	199	303	867	-
Market Cap Growth	31.96%	-34.34%	-65.09%	-	-
Enterprise Value	37	71	34	667	-55
PE Ratio	-	-1.45	-2.31	-9.04	-
PS Ratio	136.31	88.88	58.19	-	-
PB Ratio	1.05	1.08	1.00	2.19	-
P/FCF Ratio	-2.75	-1.95	-18.28	-6.47	-
P/OCF Ratio	-3.03	-2.25	21.53	-9.74	-
EV/Sales Ratio	27.01	31.59	6.54	-	-
EV/EBITDA Ratio	-1.03	-0.58	-0.28	-7.41	1.07
EV/EBIT Ratio	-0.91	-0.53	-0.26	-7.05	1.03
EV/FCF Ratio	-1.23	-0.69	-2.05	-4.98	1.08
Debt / Equity Ratio	0.25	0.25	0.16	0.06	-0.20
Debt / EBITDA Ratio	-0.37	-0.38	-0.41	-0.27	-0.41
Debt / FCF Ratio	-0.45	-0.46	-2.96	-0.18	-0.42
Quick Ratio	12.08	9.79	10.65	14.35	6.30
Current Ratio	12.44	9.92	10.72	14.57	6.51
Asset Turnover	0.00	0.01	0.01	0	0
Interest Coverage	-975.45	-248.61	-90.50	-74.12	-139.62
Return on Equity (ROE)	-64.40%	-58.90%	-38.00%	-32.60%	54.00%
Return on Assets (ROA)	-35.00%	-33.50%	-25.20%	-22.70%	-54.20%
Return on Capital (ROIC)	-65.62%	-63.33%	-38.06%	-22.55%	63.34%
Earnings Yield	-71.47%	-68.80%	-43.28%	-11.06%	-
FCF Yield	-52.83%	-51.39%	-5.47%	-15.46%	-
Buyback Yield / Dilution	-6.29%	-2.70%	-78.30%	-332.95%	-
Total Shareholder Return	-6.29%	-2.70%	-78.30%	-332.95%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).